ClinicalTrials.Veeva

Menu

Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD (IDEAL)

Pfizer logo

Pfizer

Status and phase

Completed
Phase 4

Conditions

Cardiovascular Diseases

Treatments

Drug: atorvastatin
Drug: simvastatin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00159835
ATV-N-98-001
A2581145

Details and patient eligibility

About

To investigate whether a long-term strategy to lower LDL cholesterol with atorvastatin as much as possible will improve prognosis in CHD patients compared with a strategy reflecting current best clinical practice with simvastatin.

Sex

All

Ages

Under 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Previous myocardial infarction

Exclusion criteria

  • Women who are breast feeding or are pregnant

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

194

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems